Comparison of anticoagulation and antiplatelet therapy for treatment of blunt cerebrovascular injury in children <10 years of age: a multicenter retrospective cohort study.
Vijay M RavindraRobert J BolloMichael C DewanJay K Riva-CambrinDaniel TonettiAl-Wala AwadS Hassan AkbariStephen GannonChevis ShannonYekaterina BirkasDavid LimbrickAndrew JeaRobert P NaftelJohn R KestleRamesh GrandhiPublished in: Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery (2020)
There were no observed differences in the rate of hemorrhagic complications between anticoagulation and antiplatelet therapy for BCVI in children < 10 years, with a nonsignificantly better rate of healing on follow-up imaging in children who underwent antiplatelet therapy; however, the study cohort was small despite including patients from 5 hospitals.
Keyphrases
- antiplatelet therapy
- acute coronary syndrome
- percutaneous coronary intervention
- young adults
- end stage renal disease
- atrial fibrillation
- venous thromboembolism
- coronary artery disease
- healthcare
- newly diagnosed
- chronic kidney disease
- ejection fraction
- high resolution
- peritoneal dialysis
- clinical trial
- cross sectional
- mass spectrometry
- combination therapy
- patient reported outcomes